Novanta Inc. Common Stock
NOVTNovanta Inc. is a technology provider that develops and manufactures intelligent motion, imaging, and optical systems for advanced medical, industrial, and electronics markets. The company's solutions are used in applications such as medical imaging, laser systems, and factory automation, emphasizing innovation and precision.
Company News
Novanta CEO Matthijs Glastra sold 6,500 shares worth ~$878,458 on Feb. 2, 2026, as part of a pre-established Rule 10b5-1 trading plan adopted in September 2025. The sale is not a warning sign, as the stock has surged 23% year-to-date in 2026 driven by strong business performance and 17% bookings growth. However, with a P/E ratio near 100, the ana...
American Capital Management increased its Novanta position by 163,005 shares in Q4 2025 for approximately $18.56 million, bringing its total stake to 381,866 shares valued at $45.44 million. While the fund shows confidence in the company, Novanta faces headwinds including meager 1.4% revenue growth and a lofty 99x P/E ratio, though signs of marke...
ACK Asset Management acquired 375,000 shares of Novanta worth $44.62 million in February 2026, making it a 5.6% position in the fund. Despite the stock being flat over the past year and underperforming the S&P 500, the investment suggests confidence in potential recovery as medical and advanced industrial demand rebounds. Novanta generated nearly...
Conestoga Capital Advisors sold $20.1 million worth of Novanta stock in Q3, reducing its stake by 168,907 shares due to weak stock performance and sector headwinds, while maintaining a significant position in the company.
Macroeconomic challenges are hurting the Zacks Electronics - Miscellaneous Components industry. However, industry participants like NOVT, OSIS, ROG and AMSC are set to gain from AI and IoT prospects.
